Cipla, Boehringer Ingelheim to co-market oral anti-diabetic drugs Oboravo, Oboravo Met, Tiptengio Ruchika Sharma30 Jun 2020 11:28 AM ISTThe Indian diabetes market is valued at INR 1,45,451 million and is growing at 10.35% (IMS MAT May 2020) with the oral anti-diabetic market being...
Lixisenatide lowers postprandial blood sugar spikes in diabetics after pancreatectomy Dr.Niharika Harsha B30 Jun 2020 10:45 AM ISTLixisenatide, a glucagon-like peptide 1 receptor agonist (GLP-1agonist) effectively reduces postprandial blood sugar excursions in totally...
Delhi HC restrains firm from infringing Merck diabetes drug Sitagliptin Farhat Nasim28 Jun 2020 11:15 AM IST"It appears that if Merck Sharp & Dohme Corp are not protected, their interest would get jeopardized. Furthermore, it would also affect the interest...
Merck goes against Dr Reddys alleging patent infringement of diabetes drug Januvia, Janumet Farhat Nasim28 Jun 2020 10:45 AM ISTMerck in its petition filed on June 23, said Dr Reddys had submitted ANDAs (abbreviated new drug application) to the US FDA seeking approval from the...
Diabetes drug Metformin may lower risk of COVID-19 death in diabetic women Dr. Kamal Kant Kohli25 Jun 2020 7:30 PM ISTResearchers have found in an observational study that diabetes drug Metformin may lower risk of COVID-19 death in women.Type2 diabetes (T2DM) and...
Ertugliflozin reduces hospitalization risk due to heart failure in diabetes Medha Baranwal25 Jun 2020 10:45 AM ISTDelhi: SGTL2 inhibitor ertugliflozin reduces heart failure hospitalization risk but does not confer a cardiovascular mortality benefit in...
New diabetes drug lowers blood sugar without inducing vomiting, weight loss Dr. Kamal Kant Kohli24 Jun 2020 9:08 AM ISTSyracuse, NY. - Scientists at Syracuse University chemistry have developed a new drug that controls blood sugar without the common side effects of...
Thiazolidinediones may protect diabetics from Parkinson's disease Medha Baranwal23 Jun 2020 10:30 AM ISTDelhi: Thiazolidinediones (TZDs) exhibit a neuroprotective effect against Parkinson's disease (PD) particularly in patients with type 2 diabetes...
SGLT2 inhibitor Bexagliflozin reduces blood sugar, high BP and weight in diabetics Medha Baranwal19 Jun 2020 5:30 PM ISTDelhi: The investigational drug Bexagliflozin was found to be well-tolerated in high-risk diabetes patients in a phase 3 study. According to the...
Metformin and SGLT2 Inhibitor combo helps attain HbA1c of <8% in most Diabetics Dr.Niharika Harsha B18 Jun 2020 10:44 AM ISTComplex pathophysiology and multiple physiological factors play a key role in the onset and the progression of Diabetes Mellitus. Combination therapy...
ADA 2020: Empagliflozin reduces insulin need in diabetes patients Medha Baranwal17 Jun 2020 8:36 PM ISTDelhi: Treatment with the SGLT2 inhibitor empagliflozin reduces dependency on insulin in patients with type 2 diabetes (T2D) and cardiovascular...
Vildagliptin as good as metformin in controlling blood sugar in diabetes Medha Baranwal17 Jun 2020 12:00 PM ISTDelhi: Vildagliptin or metformin showed similar protective effects on the beta-cell function, reduced insulin resistance, and blood sugar...
